These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22721842)

  • 1. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease.
    Billioud V; Gibot S; Massin F; Oussalah A; Chevaux JB; Williet N; Bronowicki JP; Bigard MA; Guéant JL; Peyrin-Biroulet L
    Dig Liver Dis; 2012 Jun; 44(6):466-70. PubMed ID: 22341488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.
    Park JJ; Cheon JH; Kim BY; Kim DH; Kim ES; Kim TI; Lee KR; Kim WH
    Dig Dis Sci; 2009 Jul; 54(7):1525-31. PubMed ID: 18975078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity.
    Saurer L; Rihs S; Birrer M; Saxer-Seculic N; Radsak M; Mueller C;
    J Crohns Colitis; 2012 Oct; 6(9):913-23. PubMed ID: 22410349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.
    Tzivras M; Koussoulas V; Giamarellos-Bourboulis EJ; Tzivras D; Tsaganos T; Koutoukas P; Giamarellou H; Archimandritis A
    World J Gastroenterol; 2006 Jun; 12(21):3416-9. PubMed ID: 16733861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) are correlated with disease activity in rheumatoid arthritis.
    Choi ST; Kang EJ; Ha YJ; Song JS
    J Rheumatol; 2012 May; 39(5):933-8. PubMed ID: 22422501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
    Miranda-García P; Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2016 Oct; 39(8):508-15. PubMed ID: 27020243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
    Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH;
    Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis.
    Chen CH; Liao HT; Chen HA; Liang TH; Wang CT; Chou CT
    J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the concordance between biological markers and clinical activity in inflammatory bowel disease].
    Miranda García P; Chaparro M; Gisbert JP
    Med Clin (Barc); 2015 Jan; 144(1):9-13. PubMed ID: 24530050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
    Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of plasma citrulline levels with clinical and endoscopic score and blood markers according to small bowel involvement in pediatric Crohn disease.
    Lee EH; Ko JS; Seo JK
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):570-5. PubMed ID: 23752073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
    Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
    Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.